Oncotarget · 2015 · 57 citations · 32 references
Life SciencesImmunologyImmunoregulationImmunotherapyInflammationDendritic Cell BiologyDendritic Cell RegulationImmune DysregulationInflammatory Cell ResponsesInflammatory Response RegulationInflammatory SignalingDendritic Cell Tolerance InductionDendritic Cell Tolerogenic FunctionDendritic Cell TolerogenicityGlycolysisNf-κb SignalingTolerogenic Dendritic Cell TherapyTolerogenic Dendritic CellsTolerogenic Immunotherapy
// Klára Dáňová 1,2 , Anna Klapetková 1,2 , Jana Kayserová 2 , Anna Šedivá 2 , Radek Špíšek 1,2 and Lenka Palová Jelínková 1,2 1 Sotio a.s., Prague, Czech Republic 2 Department of Immunology, Charles University, 2nd Medical School, Prague, Czech Republic Correspondence to: Lenka Palová Jelínková, email: // Keywords : tolerogenic DCs, immunoregulation, stability, activation pathways, glycolysis Received : May 05, 2015 Accepted : May 12, 2015 Published : May 22, 2015 Abstract Tolerogenic dendritic cells (tDCs) may offer an intervention therapy in autoimmune diseases or transplantation. Stable immaturity and tolerogenic function of tDCs after encountering inflammatory environment are prerequisite for positive outcome of immunotherapy. However, the signaling pathways regulating their stable tolerogenic properties are largely unknown. In this study, we demonstrated that human monocyte-derived tDCs established by using paricalcitol (analogue of vitamin D2), dexamethasone and monophosphoryl lipid A exposed for 24h to LPS, cytokine cocktail, polyI:C or CD40L preserved reduced expression of co-stimulatory molecules, increased levels of inhibitory molecules ILT-3, PDL-1 and TIM-3, increased TLR-2, increased secretion of IL-10 and TGF-β, reduced IL-12 and TNF-α secretion and reduced T cell stimulatory capacity. tDCs further induced IL-10-producing T regulatory cells that suppressed the proliferation of responder T cells. In the inflammatory environment, tDCs maintained up-regulated indoleamine 2, 3 dioxygenase but abrogated IκB-α phosphorylation and reduced transcriptional activity of p65/RelA, RelB and c-Rel NF-κB subunits except p50. Mechanistically, p38 MAPK, ERK1/2, mTOR, STAT3 and mTOR-dependent glycolysis regulated expression of ILT-3, PDL-1 and CD86, secretion of IL-10 and T cell stimulatory capacity of tDCs in the inflammatory environment. Stability of tDCs in the inflammatory environment is thus regulated by multiple signaling pathways.
32
Helmut Jonuleit, Edgar Schmitt, Gerold Schuler et al. · The Journal of Experimental Medicine · 2000 · 1.5K citations · Full text
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
Connie M. Krawczyk, Thomas Holowka, Jie Sun et al. · Blood · 2010 · 1.2K citations · Full text
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart, Giuseppina Costantino, Marko Poglitsch et al. · Immunity · 2008 · 802 citations · Full text